Resveratrol induces the expression of the E3 ligase β-TrCP, which catalyzes ubiquitination of non-glycosylated PD-L1 and thus causes reduced PD-L1 expression and enhanced anti-tumor T cells immunity in breast cancer [18,25]. This evidence concerns the gene CD274 and neoplasm.